Latest Research in Influenza Virus Research Studies
34 research papers · 0.0 average citations · 2026 median publication year
Top Research Topics in Influenza Virus Research Studies
- SARS-CoV-2 and COVID-19 Research — 9 papers
- Influenza Virus Research Studies — 6 papers
- HIV Research and Treatment — 5 papers
- Respiratory viral infections research — 2 papers
- Viral Infections and Immunology Research — 2 papers
- Pediatric health and respiratory diseases — 1 papers
- Viral Infectious Diseases and Gene Expression in Insects — 1 papers
- Animal Virus Infections Studies — 1 papers
- Ocular Infections and Treatments — 1 papers
- Mosquito-borne diseases and control — 1 papers
Highest-Cited Papers
- Immunological imprinting shapes the cross-reactive antibody responses to the KP.2 and LP.8.1 vaccine doses (1 citations)
- Immunogenetic determinants of influenza B virus susceptibility and vaccine response: current evidence, gaps, and future directions
- Peripheral human mAb therapy yields modulation of neuroinflammation and long-term functional recovery from lyssavirus infection
- Mechanistic blockade of RSV infection by a pre-F targeting single-domain antibody-Fc fusion protein
- The Silent Vehicle: Validating the Biological Signals and Noises of Baculovirus Vectors in Macrophage-Targeted Vaccines
- Mutational constraints on RSV F and its neutralization by antibodies
- Mechanisms of antibody-dependent enhancement and its research progress in animal coronaviruses
- Dimethyl Sulfoxide Modulates T Cell–Mediated Immunity to Attenuate Influenza A Virus Infection
- Direct detection and quantification of HIV particles and their envelope trimers bound by combinations of broadly neutralizing antibodies
- R1-32-like public antibodies acquire tolerance to SARS-CoV-2 antigenic drift through somatic hypermutation
- Immunogenicity and Safety of a Single Booster Dose of Sabin-Strain Inactivated Poliovirus Vaccine in Adolescents and Adults: A Phase IV, Open-Label Trial
- Vaccines for microbial eye diseases in the era of data science: opportunities and challenges
- Preclinical toxicity and immunogenicity of a quadrivalent recombinant influenza hemagglutinin vaccine (SCVC101) in rhesus monkeys
- Encephalitic alphavirus infection induces long-term humoral and cell-mediated responses in seropositive participants from Panama
- Safety and immunogenicity of mRNA-1345 revaccination at least 12 months following primary vaccination with a licensed protein subunit RSV vaccine
- Ebola Virus RNA Persists in Reproductive Tissues and Sperm of Male Ifnar1−/− Mice After Resolution of Viremia
- Computationally guided multi-epitope vaccine design targeting oncoprotein BZLF1, EBNA1, LMP1, and LMP2 for of EBV associated gastric cancer
- A dimeric mRNA vaccine based on key-mutant and KP.3 RBDs induces broad-spectrum immunity and protects mice against JN.1 and XDV challenges
- Development of adjuvanted HIV vaccines tailored for early life: immunologic rationale, clinical experience, and future directions
- The adjuvant access problem: barriers to broader vaccine development